phase i/ii study of nivolumab and axitinib for advanced rcc
Published 2 years ago • 97 plays • Length 1:29Download video MP4
Download video MP3
Similar videos
-
0:57
avelumab and axitinib for the treatment of advanced rcc
-
2:31
axitinib plus pembrolizumab in advanced rcc
-
2:18
pembrolizumab monotherapy and pembro-axitinib for rcc
-
0:54
phase ib/ii trial of 177lu-girentuximab with cabozantinib and nivolumab in clear cell rcc
-
2:16
dr. rini on axitinib for treatment of metastatic renal cell carcinoma
-
3:30
promising results for axitinib and pembrolizumab in advanced renal cell cancer
-
2:23
overview of a phase iii trial of pembrolizumab plus axitinib in rcc
-
56:27
ccf webinar: a clinical trial for a potential new ther2apy for biliary tract cancers
-
1:00
pembrolizumab/axitinib and avelumab/axitinib combo for rcc
-
8:26
front-line therapy with nivolumab and salvage nivolumab ipilimumab in patients with advanced rcc
-
5:10
checkmate 214: patterns of progression with nivolumab plus ipilimumab versus sunitinib for rcc
-
1:03
dr. hutson discusses the phase iii atlas study in rcc
-
5:10
real-world treatment outcomes of 1l axitinib pembrolizumab in patients with advanced rcc in the us
-
9:09
nivolumab with alternatively scheduled ipilimumab in first-line treatment of advanced rcc
-
2:25
dr. motzer on a phase ii trial of nivolumab for mrcc
-
4:15
two positive phase iii rcc studies, nivolumab approved for nsclc in europe, and more
-
1:37
dr. shuch on caveats of avelumab/axitinib combination in rcc
-
4:01
cosmic-313: cabo nivo ipi in 1l advanced rcc of imdc intermediate or poor risk
-
6:01
dart study: phase 2 study of dalantercept plus axitinib in advanced clear cell rcc